PACS Group, Inc.
NYSEPACS Group reports Q1 results on May 20 carrying a sharply different positioning picture than it had just six weeks ago. Short interest has climbed 30% over the past month to 3% of the free float, while the stock itself has rallied 13% over the same period — a divergence that frames the debate heading into tomorrow's print. The most notable shift is in short positioning. Bears have…
PACS put-call ratio spikes to 0.1821, jumping 4.2 standard deviations above its 20-day mean of 0.1201—signaling extreme bullish sentiment as the stock surges 22% over one month.
Snapshot as of 28 Jun 2026
PACS Group reports Q1 results on May 20 carrying a sharply different positioning picture than it had just six weeks ago. Short interest has climbed 30% over the past month to 3% of the free float, while the stock…
PACS Group delivered one of the more striking single-week moves in the healthcare space, surging 26% after a Q1 earnings beat that forced both bulls and remaining sceptics to reprice their positions. The catalyst…
PACS Group reports Q1 2026 results today with a notable insider selling pattern casting a shadow over the stock. A cluster of C-suite sales in April tells the clearest story heading into the print. On April 15, the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PACS — free to start on ORTEX.
Sign up for free →Open PACS on ORTEX